PCI Biotech Holding ASA (FRA:4QG) Total Assets : €4.49 Mil (As of Jun. 2023)

View and export this data going back to 2008. Start your Free Trial

What is PCI Biotech Holding ASA Total Assets?

PCI Biotech Holding ASA's Total Assets for the quarter that ended in Jun. 2023 was €4.49 Mil.

During the past 12 months, PCI Biotech Holding ASA's average Total Assets Growth Rate was -56.70% per year. During the past 3 years, the average Total Assets Growth Rate was -47.10% per year. During the past 5 years, the average Total Assets Growth Rate was -20.50% per year. During the past 10 years, the average Total Assets Growth Rate was 3.40% per year.

During the past 13 years, PCI Biotech Holding ASA's highest 3-Year average Total Assets Growth Rate was 38.60%. The lowest was -47.10%. And the median was 10.60%.

Total Assets is connected with ROA %. PCI Biotech Holding ASA's annualized ROA % for the quarter that ended in Jun. 2023 was -41.00%. Total Assets is also linked to Revenue through Asset Turnover. PCI Biotech Holding ASA's Asset Turnover for the quarter that ended in Jun. 2023 was 0.00.

PCI Biotech Holding ASA Total Assets Historical Data

The historical data trend for PCI Biotech Holding ASA's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PCI Biotech Holding ASA Total Assets Chart

PCI Biotech Holding ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

28.13

19.74

13.40

6.07

3.83

PCI Biotech Holding ASA Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
Total Assets	Get a 7-Day Free Trial															7.25	6.07	5.11	4.49	3.83

PCI Biotech Holding ASA Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

PCI Biotech Holding ASA's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	3.394	+	0.435
	=	3.83

PCI Biotech Holding ASA's Total Assets for the quarter that ended in Jun. 2023 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2023 )	+	Total Liabilities (Q: Jun. 2023 )
	=	4.01	+	0.48
	=	4.49

PCI Biotech Holding ASA (FRA:4QG) Total Assets Explanation

Total Assets is connected with ROA %.

PCI Biotech Holding ASA's annualized ROA % for the quarter that ended in Jun. 2023 is

ROA %	=	Net Income (Q: Jun. 2023 )	/	( (Total Assets (Q: Mar. 2023 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
	=	-1.968	/	( (5.109	+	4.49)	/ 2 )
	=	-1.968	/	4.7995
	=	-41.00 %

Note: The Net Income data used here is four times the quarterly (Jun. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

PCI Biotech Holding ASA's Asset Turnover for the quarter that ended in Jun. 2023 is

	Asset Turnover
=	Revenue (Q: Jun. 2023 )	/	( (Total Assets (Q: Mar. 2023 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
=	0	/	( (5.109	+	4.49)	/ 2 )
=	0	/	4.7995
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

PCI Biotech Holding ASA Total Assets Related Terms

Thank you for viewing the detailed overview of PCI Biotech Holding ASA's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

PCI Biotech Holding ASA (FRA:4QG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PCI Biotech Holding ASA (FRA:4QG) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

PCIB:Norway

Address

Ullernchausseen 64, Oslo, NOR, N-0379

Website

https://www.pcibiotech.com

PCI Biotech Holding ASA is a biopharmaceutical company. It focuses on developing and commercializing therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The PCI technology works by inducing light-triggered endosomal release. PCI is applied to three distinct anticancer paradigms; fimaCHEM which is an enhancement of chemotherapeutics for localized treatment of cancer, fimaVACC which is T-cell induction technology for therapeutic vaccination, and fimaNAc which is nucleic acid therapeutics delivery. Its therapeutic product candidate is the photosensitizer fimaporfin (Amphinex) which can unlock the intracellular capsules where active compounds are trapped.

PCI Biotech Holding ASA (FRA:4QG) Headlines

No Headlines